Investors NYSE AMERICAN: LCTX Minimum 15 minutes delayed. Source: LSEG VIEW STOCK QUOTE Press Releases January 06, 2025 Lineage Cell Therapeutics Issues Letter to Stockholders November 21, 2024 Lineage Cell Therapeutics Announces First Closing of up to $66 Million Registered Direct Offering November 20, 2024 Lineage Cell Therapeutics Announces Pricing of up to $66 Million Registered Direct Offering VIEW PRESS RELEASES Events & Presentations Roche Pharma Day 2024 Presentation 8.9 MB Lineage Cell Therapeutics Corporate Overview August 8, 2024 5.3 MB 2024 Retinal Cell & Gene Therapy Innovation Summit Presentation 1.6 MB Third Quarter 2024 Financial Results Earnings Call Nov 14, 2024 at 4:30 PM EST Click here for webcast VIEW EVENTS & PRESENTATIONS
November 21, 2024 Lineage Cell Therapeutics Announces First Closing of up to $66 Million Registered Direct Offering
November 20, 2024 Lineage Cell Therapeutics Announces Pricing of up to $66 Million Registered Direct Offering
Third Quarter 2024 Financial Results Earnings Call Nov 14, 2024 at 4:30 PM EST Click here for webcast
